Year |
Citation |
Score |
2001 |
Dugar A, Jane Keck B, Maines LW, Miller S, Njai R, Lakoski JM. Compensatory responses in the aging hippocampal serotonergic system following neurodegenerative injury with 5,7-dihydroxytryptamine Synapse. 39: 109-121. PMID 11180498 DOI: 10.1002/1098-2396(200102)39:2<109::Aid-Syn2>3.0.Co;2-B |
0.444 |
|
2000 |
Keck BJ, Lakoski JM. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ Neuropharmacology. 39: 1237-1246. PMID 10760365 DOI: 10.1016/S0028-3908(99)00218-X |
0.339 |
|
1999 |
Maines LW, Keck BJ, Smith JE, Lakoski JM. Corticosterone regulation of serotonin transporter and 5-HT(1A) receptor expression in the aging brain Synapse. 32: 58-66. PMID 10188639 DOI: 10.1002/(Sici)1098-2396(199904)32:1<58::Aid-Syn8>3.0.Co;2-R |
0.457 |
|
1998 |
Maines LW, Polavarapu R, Lakoski JM. Expression of brain G(i) protein in the aging F344 rat following exposure to corticosterone International Journal of Developmental Neuroscience. 16: 341-346. PMID 9829170 DOI: 10.1016/S0736-5748(98)00042-2 |
0.316 |
|
1998 |
Smith JE, Lakoski JM. Cellular electrophysiological effects of chronic fluoxetine and duloxetine administration on serotonergic responses in the aging hippocampus Synapse. 30: 318-328. PMID 9776135 DOI: 10.1002/(Sici)1098-2396(199811)30:3<318::Aid-Syn9>3.0.Co;2-E |
0.438 |
|
1998 |
Maines LW, Keck BJ, Dugar A, Lakoski JM. Age-dependent loss of corticosterone modulation of central serotonin 5- HT(1A) receptor binding sites Journal of Neuroscience Research. 53: 86-98. PMID 9670995 DOI: 10.1002/(Sici)1097-4547(19980701)53:1<86::Aid-Jnr9>3.0.Co;2-F |
0.414 |
|
1997 |
Keck BJ, Lakoski JM. N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT(1A) receptor binding site inactivation and turnover Brain Research Protocols. 1: 364-370. PMID 9384817 DOI: 10.1016/S1385-299X(97)00012-3 |
0.312 |
|
1997 |
Smith JE, Lakoski JM. Electrophysiological study of the effects of the reuptake inhibitor duloxetine on serotonergic responses in the aging hippocampus Pharmacology. 55: 66-77. PMID 9323306 DOI: 10.1159/000139514 |
0.44 |
|
1997 |
Smith JE, Lakoski JM. Electrophysiological effects of fluoxetine and duloxetine in the dorsal raphe nucleus and hippocampus European Journal of Pharmacology. 323: 69-73. PMID 9105878 DOI: 10.1016/S0014-2999(97)00024-1 |
0.366 |
|
1997 |
Dugar A, Lakoski JM. Serotonergic function of aging hippocampal CA3 pyramidal neurons: Electrophysiological assessment following administration of 5,7- dihydroxytryptamine in the fimbria-fornix and cingulum bundle Journal of Neuroscience Research. 47: 58-67. PMID 8981238 DOI: 10.1002/(Sici)1097-4547(19970101)47:1<58::Aid-Jnr6>3.0.Co;2-E |
0.448 |
|
1996 |
Keck BJ, Lakoski JM. Age-related assessment of central 5-HT(1A) receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) Brain Research. 728: 130-134. PMID 8864308 DOI: 10.1016/S0006-8993(96)00481-7 |
0.324 |
|
1996 |
Lakoski JM, Dugar A, Keck BJ. [8] Neurochemical lesions: Tools for functional assessment of serotonin neuronal systems Methods in Neurosciences. 30: 115-123. DOI: 10.1016/S1043-9471(96)80100-5 |
0.309 |
|
1989 |
Halpern RE, Black EW, Lakoski JM. Aging but not estrogen alters regional [3H]5-HT binding in the CNS of female Fischer 344 rats. Neuroscience Letters. 101: 293-8. PMID 2771173 DOI: 10.1016/0304-3940(89)90548-X |
0.317 |
|
1988 |
Cunningham KA, Lakoski JM. Electrophysiological effects of cocaine and procaine on dorsal raphe serotonin neurons. European Journal of Pharmacology. 148: 457-62. PMID 3384007 DOI: 10.1016/0014-2999(88)90128-8 |
0.326 |
|
1985 |
Lakoski JM, Aghajanian GK. Effects of ketanserin on neuronal responses to serotonin in the prefrontal cortex, lateral geniculate and dorsal raphe nucleus. Neuropharmacology. 24: 265-73. PMID 3158835 DOI: 10.1016/0028-3908(85)90130-3 |
0.339 |
|
1984 |
Lakoski JM, Gebhart GF. Depression of neuronal activity in the hypothalamic ventromedial nucleus of the rat following microinjection of morphine in the amygdala or the periaqueductal gray. Neuroscience. 12: 255-66. PMID 6462448 DOI: 10.1016/0306-4522(84)90151-9 |
0.482 |
|
1982 |
Lakoski JM, Gebhart GF. Morphine administration in the amygdala or periaqueductal central gray depress serum levels of luteinizing hormone Brain Research. 232: 231-237. PMID 7055705 DOI: 10.1016/0006-8993(82)90632-1 |
0.475 |
|
1981 |
Lakoski JM, Gebhart GF. Attenuation of morphine’s depression of serum luteinizing hormone by lesions in the amygdala Neuroendocrinology. 33: 105-111. PMID 7022252 DOI: 10.1159/000123212 |
0.48 |
|
1980 |
Lakoski JM, Mohrland JS, Gebhart GF. The effect of morphine on the content of serotonin, 5-hydroxyindole acetic acid and substance-P in the nuclei raphe magnus and reticularis gigantocellularis Life Sciences. 27: 2639-2644. PMID 6163939 DOI: 10.1016/0024-3205(80)90553-6 |
0.465 |
|
Show low-probability matches. |